LPS induces greater bone and PDL loss in SPARC-null mice

Journal of Dental Research

Volumn 90, Issue 4, 2011, Pages 477-482

  Trombetta Esilva, J ^a,b   Yu, H ^a   Arias, D N ^c   Rossa Jr , C ^a,e   Kirkwood, K L ^a   Bradshaw, A D ^a,b,d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Erskine College   (United States)

^d MUSC Medical Center   (United States)

^e SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

alveolar bone resorption; BM 40; collagen; extracellular matrix; matricellular; osteonectin; periodontal diseases; periodontal ligament; SPARC

Indexed keywords

COLLAGEN TYPE 1; LIPOPOLYSACCHARIDE; OSTEONECTIN; SCLEROPROTEIN;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ALVEOLAR BONE LOSS; ANIMAL; C57BL MOUSE; CELL COUNT; CLASSIFICATION; COMPARATIVE STUDY; CONFERENCE PAPER; CONNECTIVE TISSUE; DRUG EFFECT; GENETICS; GENOTYPE; GINGIVA DISEASE; IMAGE PROCESSING; MAXILLA; MICRO-COMPUTED TOMOGRAPHY; MOUSE; MOUSE MUTANT; MOUSE STRAIN; PATHOLOGY; PERIODONTAL LIGAMENT; PERIODONTITIS; PHYSIOLOGY;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ALVEOLAR BONE LOSS; ANIMALS; CELL COUNT; COLLAGEN TYPE I; CONNECTIVE TISSUE; EXTRACELLULAR MATRIX PROTEINS; GENOTYPE; GINGIVAL DISEASES; IMAGE PROCESSING, COMPUTER-ASSISTED; LIPOPOLYSACCHARIDES; MAXILLA; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; OSTEONECTIN; PERIODONTAL LIGAMENT; PERIODONTITIS; X-RAY MICROTOMOGRAPHY;

EID: 79954614531     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510391800     Document Type: Conference Paper

References (31)

1. Arnold SA, Rivera LB, Miller AF, Carbon JG, Dineen SP, Xie Y., et al. (2010). Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma. Dis Model Mech 3: 57-72.
2. Boskey AL, Moore DJ, Amling M., Canalis E., Delany AM (2003). Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls. J Bone Miner Res 18: 1005-1011. (Pubitemid 37294936)
3. Bradshaw AD (2009). The role of SPARC in extracellular matrix assembly. J Cell Commun Signal 3: 239-246.
4. Bradshaw AD, Sage EH (2001). SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107: 1049-1054. (Pubitemid 32422898)
5. Bradshaw AD, Graves DC, Motamed K., Sage EH (2003 a). SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. Proc Natl Acad Sci USA 100: 6045-6050. (Pubitemid 36576928)
6. Bradshaw AD, Puolakkainen P., Dasgupta J., Davidson JM, Wight TN, Sage EH (2003 b). SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength. J Invest Dermatol 120: 949-955. (Pubitemid 36702902)
7. Bradshaw AD, Baicu CF, Rentz TJ, Van Laer AO, Boggs J., Lacy JM, et al. (2009). Pressure overload-induced alterations in fibrillar collagen content and myocardial diastolic function: role of secreted protein acidic and rich in cysteine (SPARC) in post-synthetic procollagen processing. Circulation 119: 269-280.
8. Cochran DL, Jones A., Heijl L., Mellonig JT, Schoolfield J., King GN (2003). Periodontal regeneration with a combination of enamel matrix proteins and autogenous bone grafting. J Periodontol 74: 1269-1281. (Pubitemid 37345089)
9. Delany AM, Hankenson KD (2009). Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling. J Cell Commun Signal 3: 227-238.
10. Delany AM, Amling M., Priemel M., Howe C., Baron R., Canalis E. (2000). Osteopenia and decreased bone formation in osteonectin-deficient mice. J Clin Invest 105: 915-923 ; erratum in J Clin Invest 105: 1325, 2000.
11. Diedrich P., Fritz U., Kinzinger G., Angelakis J. (2003). Movement of periodontally affected teeth after guided tissue regeneration (GTR)-an experimental pilot study in animals. J Orofac Orthop 64: 214-227. (Pubitemid 36722342)
12. Hart GT, Shaffer DJ, Akilesh S., Brown AC, Moran L., Roopenian DC, et al. (2004). Quantitative gene expression profiling implicates genes for susceptibility and resistance to alveolar bone loss. Infect Immun 72: 4471-4479. (Pubitemid 38989304)
13. Jain N., Jain GK, Javed S., Iqbal Z., Talegaonkar S., Ahmad FJ, et al. (2008). Recent approaches for the treatment of periodontitis. Drug Discov Today 13: 932-943.
14. Johnson RB (2005). Synthesis of alveolar bone Sharpey's fibers during experimental tooth movement in the rat. Anat Rec A Discov Mol Cell Evol Biol 284: 485-490. (Pubitemid 40632388)
15. Kolenbrander PE, London J. (1993). Adhere today, here tomorrow: oral bacterial adherence. J Bacteriol 175: 3247-3252. (Pubitemid 23163365)
16. Levental KR, Yu H., Kass L., Lakins JN, Egeblad M., Erler JT, et al. (2009). Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139: 891-906.
17. McCulloch CA, Lekic P., McKee MD (2000). Role of physical forces in regulating the form and function of the periodontal ligament. Periodontol 2000 24: 56-72.
18. McCurdy S., Baicu CF, Heymans S., Bradshaw AD (2010). Cardiac extracellular matrix remodeling: fibrillar collagens and Secreted Protein Acidic and Rich in Cysteine (SPARC). J Mol Cell Cardiol 48: 544-549.
19. Ng PY, Donley M., Hausmann E., Hutson AD, Rossomando EF, Scannapieco FA (2007). Candidate salivary biomarkers associated with alveolar bone loss: cross-sectional and in vitro studies. FEMS Immunol Med Microbiol 49: 252-260.
20. Norose K., Clark JI, Syed NA, Basu A., Heber-Katz E., Sage EH, et al. (1998). SPARC deficiency leads to early-onset cataractogenesis. Invest Ophthalmol Vis Sci 39: 2674-2680. (Pubitemid 28558226)
21. Rempel SA, Hawley RC, Gutierrez JA, Mouzon E., Bobbitt KR, Lemke N., et al. (2007). Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune response. Genes Immun 8: 262-274. (Pubitemid 46679437)
22. Rentz TJ, Poobalarahi F., Bornstein P., Sage EH, Bradshaw AD (2007). SPARC regulates processing of procollagen I and collagen fibrillogenesis in dermal fibroblasts. J Biol Chem 282: 22062-22071. (Pubitemid 47195756)
23. Rogers JE, Li F., Coatney DD, Rossa C., Bronson P., Krieder JM, et al. (2007). Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis. J Periodontol 78: 550-558.
24. Sartori R., Li F., Kirkwood KL (2009). MAP kinase phosphatase-1 protects against inflammatory bone loss. J Dent Res 88: 1125-1130.
25. Savage A., Eaton KA, Moles DR, Needleman I. (2009). A systematic review of definitions of periodontitis and methods that have been used to identify this disease J Clin Periodontol 36: 458-467.
26. Scannapieco FA, Ng P., Hovey K., Hausmann E., Hutson A., Wactawski-Wende J. (2007). Salivary biomarkers associated with alveolar bone loss. Ann NY Acad Sci 1098: 496-497. (Pubitemid 47092555)
27. Seymour GJ (1991). Importance of the host response in the periodontium. J Clin Periodontol 18: 421-426.
28. Sodek J. (1977). A comparison of the rates of synthesis and turnover of collagen and non-collagen proteins in adult rat periodontal tissues and skin using a microassay. Arch Oral Biol 22: 655-665. (Pubitemid 8250494)
29. Trombetta JM, Bradshaw AD (2010). SPARC/osteonectin functions to maintain homeostasis of the collagenous extracellular matrix in the periodontal ligament J Histochem Cytochem 58: 871-879.
30. Zeichner-David M. (2006). Regeneration of periodontal tissues: cementogenesis revisited. Periodontol 2000 41: 196-217. (Pubitemid 43937572)
31. Zhou X., Tan FK, Guo X., Wallis D., Milewicz DM, Xue S., et al. (2005). Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts. Arthritis Rheum 52: 257-261. (Pubitemid 40129255)